Group 1 - Veru Inc. reported a quarterly loss of 0.06pershare,betterthantheZacksConsensusEstimateofalossof0.07, and improved from a loss of 0.16pershareayearago,resultinginanearningssurpriseof14.296.66 million for the quarter ended September 2024, exceeding the Zacks Consensus Estimate by 86.99%, and up from 3.86millioninthesamequarterlastyear[2]−Overthelastfourquarters,Veruhassurpassedconsensusrevenueestimatesthreetimes[2]Group2−ThecurrentconsensusEPSestimatefortheupcomingquarteris−0.08 on revenues of 3.18million,andforthecurrentfiscalyear,itis−0.29 on revenues of $12.78 million [8] - The Zacks Industry Rank for Medical - Products is in the top 33% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [9]